More PainChek Ltd news
PainChek LtdASX: PCK

US nursing home study to pave way for FDA De Novo clearance

Aug 24, 2023 at 1:38 AM EDT · Issued by PainChek Ltd

Filed with ASX · Aug 24, 2023 at 1:38 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/us-nursing-home-study-to-pave-way-for-fda-de-novo-clearance

PainChek Ltd on 6ix

Earlier from PainChek

  • PainChek receives $1.049m R&D Tax Incentive RefundJul 24, 2023
  • Ethos Laboratories Distribution AgreementJun 15, 2023
  • AGM CEO PresentationNov 22, 2022
  • Response to ASX QuerySep 30, 2022
  • PCK expands activities to Japan with JETRO business connectSep 25, 2022

Later from PainChek

  • PainChek A$3.55m PlacementSep 14, 2023
  • Response to ASX Price QueryOct 9, 2023
  • Quarterly Update and Appendix 4COct 30, 2023
  • Notice of Acceptance for European PatentNov 20, 2023
  • Underwritten Share Purchase Plan to raise AUD $2.5 millionFeb 13, 2024
All PainChek news releases↗

Follow PainChek into a list and get an email when it puts out news.

Follow PainChek
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer